Range Financial Group LLC Takes Position in DaVita Inc. (NYSE:DVA)

Range Financial Group LLC acquired a new stake in DaVita Inc. (NYSE:DVA) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 2,947 shares of the company’s stock, valued at approximately $407,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. State of Michigan Retirement System boosted its holdings in DaVita by 0.6% during the fourth quarter. State of Michigan Retirement System now owns 15,939 shares of the company’s stock worth $1,670,000 after buying an additional 100 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of DaVita by 18.8% in the 1st quarter. GAMMA Investing LLC now owns 657 shares of the company’s stock valued at $91,000 after acquiring an additional 104 shares in the last quarter. Treasurer of the State of North Carolina lifted its position in shares of DaVita by 0.5% in the 3rd quarter. Treasurer of the State of North Carolina now owns 24,503 shares of the company’s stock valued at $2,316,000 after acquiring an additional 123 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in shares of DaVita by 1.0% in the 3rd quarter. PNC Financial Services Group Inc. now owns 15,088 shares of the company’s stock valued at $1,426,000 after acquiring an additional 153 shares in the last quarter. Finally, Meridian Wealth Management LLC lifted its position in shares of DaVita by 2.9% in the 4th quarter. Meridian Wealth Management LLC now owns 5,921 shares of the company’s stock valued at $620,000 after acquiring an additional 166 shares in the last quarter. 90.12% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. Truist Financial upped their price target on shares of DaVita from $135.00 to $150.00 and gave the company a “hold” rating in a research report on Wednesday, May 15th. Barclays lifted their price objective on DaVita from $133.00 to $150.00 and gave the company an “equal weight” rating in a research report on Monday, May 6th. Finally, StockNews.com downgraded DaVita from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 8th. Two analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $144.67.

Insider Buying and Selling

In related news, Director Barbara J. Desoer sold 5,030 shares of the company’s stock in a transaction on Friday, May 10th. The shares were sold at an average price of $138.81, for a total transaction of $698,214.30. Following the completion of the sale, the director now directly owns 10,954 shares of the company’s stock, valued at approximately $1,520,524.74. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 2.00% of the stock is owned by insiders.

DaVita Stock Performance

DVA stock opened at $143.97 on Tuesday. The company has a quick ratio of 1.37, a current ratio of 1.43 and a debt-to-equity ratio of 7.95. The company has a market capitalization of $12.63 billion, a price-to-earnings ratio of 16.36, a P/E/G ratio of 1.08 and a beta of 0.96. DaVita Inc. has a 12 month low of $71.51 and a 12 month high of $147.93. The firm has a 50 day moving average of $138.64 and a two-hundred day moving average of $125.93.

DaVita (NYSE:DVA) last posted its earnings results on Thursday, May 2nd. The company reported $2.38 EPS for the quarter, topping the consensus estimate of $1.95 by $0.43. The company had revenue of $3.07 billion during the quarter, compared to the consensus estimate of $3.03 billion. DaVita had a net margin of 6.61% and a return on equity of 68.52%. The company’s revenue for the quarter was up 6.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.58 earnings per share. As a group, equities analysts anticipate that DaVita Inc. will post 9.62 EPS for the current fiscal year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.